Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2011-02-14 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SEGONZAC (16130), Charente
PHARMACIE DE SEGONZAC : revenue, balance sheet and financial ratios
PHARMACIE DE SEGONZAC is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SEGONZAC (16130),
this company of category PME
shows in 2023 a revenue of 3.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE SEGONZAC (SIREN 530307230)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 951 356 €
2 886 803 €
2 759 154 €
2 430 142 €
2 233 047 €
2 186 828 €
2 100 326 €
Net income
275 867 €
233 776 €
290 774 €
400 244 €
356 861 €
318 751 €
301 693 €
283 963 €
259 732 €
EBITDA
N/C
N/C
395 727 €
552 448 €
510 153 €
460 668 €
426 277 €
426 328 €
391 084 €
Net margin
N/C
N/C
9.9%
13.9%
12.9%
13.1%
13.5%
13.0%
12.4%
Revenue and income statement
In 2025, PHARMACIE DE SEGONZAC generates positive net income of 276 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 260 k€ -> 276 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
275 867 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 85%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.085%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
84.528%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE SEGONZAC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
95.047
78.286
52.807
38.066
25.417
16.053
7.266
0.035
0.085
Financial autonomy
46.255
50.611
59.502
64.478
71.045
76.871
81.801
85.396
84.528
Repayment capacity
3.651
3.369
2.405
1.818
1.23
0.735
0.481
None
None
Cash flow / Revenue
13.105%
13.19%
13.704%
13.469%
13.25%
14.144%
10.179%
None%
None%
Sector positioning
Debt ratio
0.092025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent
In 2025, the debt ratio of PHARMACIE DE SEGONZAC (0.09) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
84.53%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent+10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE SEGONZAC (84.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.48 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DE SEGONZAC (0.48) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 194.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
194.701
Liquidity indicators evolution PHARMACIE DE SEGONZAC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
240.008
283.98
265.947
242.294
260.832
250.829
223.047
201.526
194.701
Interest coverage
7.051
5.944
5.238
3.806
2.649
1.742
1.441
None
None
Sector positioning
Liquidity ratio
194.72025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good-6 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE SEGONZAC (194.70) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.44x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DE SEGONZAC (1.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE SEGONZAC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
255 862 €
423 785 €
360 257 €
466 077 €
374 003 €
354 615 €
511 322 €
0 €
0 €
Inventory turnover (days)
32
31
32
29
28
28
32
0
0
Customer payment term (days)
5
8
7
7
7
5
5
0
0
Supplier payment term (days)
45
51
41
44
40
38
41
0
0
Positioning of PHARMACIE DE SEGONZAC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE SEGONZAC is estimated at
4 382 180 €
(range 2 973 768€ - 6 876 244€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2973k€4382k€6876k€
4 382 180 €Range: 2 973 768€ - 6 876 244€
NAF 5 année 2025
Valuation method used
Net Income Multiple
275 867 €
×
15.9x
=4 382 180 €
Range: 2 973 768€ - 6 876 244€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE SEGONZAC with other companies in the same sector:
Frequently asked questions about PHARMACIE DE SEGONZAC
What is the revenue of PHARMACIE DE SEGONZAC ?
The revenue of PHARMACIE DE SEGONZAC in 2023 is 3.0 M€.
Is PHARMACIE DE SEGONZAC profitable?
Yes, PHARMACIE DE SEGONZAC generated a net profit of 276 k€ in 2025.
Where is the headquarters of PHARMACIE DE SEGONZAC ?
The headquarters of PHARMACIE DE SEGONZAC is located in SEGONZAC (16130), in the department Charente.
Where to find the tax return of PHARMACIE DE SEGONZAC ?
The tax return of PHARMACIE DE SEGONZAC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE SEGONZAC operate?
PHARMACIE DE SEGONZAC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart